Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum
Turn Therapeutics will present at the Stifel 2026 Virtual Immunology and Inflammation Forum on September 23, 2026 at 1:30 PM ET, with CEO Bradley Burnam and Executive Clinical and Regulatory Lead Dr. Stephen M. Hahn delivering the presentation. The presentation will detail the company's atopic dermatitis clinical program, including its pruritus-focused stage 2 enrichment strategy and emerging findings across patient subgroups such as those with lower EASI scores despite high investigator-assessed disease severity.
Key figures
- Presentation date
- September 23, 2026
- Presentation time
- 1:30 PM ET
- Webcast replay window
- approximately six months
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.